参考文献/References:
[1] Rigau V, Zouaoui S, Mathieu-Daude H, et al. French brain tumor DataBase:5-Year histological results on 25756 cases[J]. Brain Pathology, 2011, 21(6):633-644. DOI:10.1111/j.1750-3639.2011. 00491.x.
[2] Kros JM.Grading of gliomas:the road from eminence to evidence[J].J Neuropathol Exp Neurol, 2011, 70(2):101-109. DOI:10.1097/NEN.0b013e31820681aa.
[3] 任彦, 庞浩鹏, 狄宁宁, 等. 脑胶质瘤体素内不相干运动弥散加权成像与T1动态对比增强磁共振成像相关性研究[J]. 肿瘤影像学, 2016, 25(3):223-232. Ren Y, Pang HP, Di NN, et al. Correlative assessment of perfusion-related parameters of intravoxel incoherent motion with dynamic contrast;enhancement in MR imaging of gliomas[J]. Oncoradiology, 2016, 25(3):223-232.
[4] Van Den Bent MJ, Vogelbaum MA, Wen PY, et al. End point assessment in gliomas:novel treatments limit usefulness of classical Macdonald’s Criteria[J]. J Clin Oncol, 2009, 27(18):2905-2908. DOI:10.1200/JCO.2009.22.4998.
[5] Reddy K, Westerly D, Chen C. MRI patterns of T1 enhancing radiation necrosis versus tumour recurrence in high-grade gliomas[J]. J Med Imaging Radiat Oncol, 2013, 57(3):349-355. DOI:10.1111/j.1754-9485.2012.02472.x.
[6] Zitron IM, Kamson DO, Kiousis S, et al. In vivo metabolism of tryptophan in meningiomas is mediated by indoleamine 2,3-dioxygenase 1[J]. Cancer Biol Ther, 2013, 14:333-339. DOI:10.4161/cbt. 23624.
[7] Van Waarde A, Elsinga PH.Proliferation markers for the differential diagnosis of tumor and inflammation[J]. Curr Pharm Des, 2008, 14(31):3326-3339.
[8] Nabors LB, Ammirati M, Bierman PJ, et al. Central nervous system cancers[J]. J Natl Compr Canc Netw, 2013, 11(9):1114-1151.
[9] Galldiks N, Kracht LW, Berthold F, et al. 11C-L-methionine positron emission tomography in the management of children and young adults with brain tumors[J]. J Neurooncol, 2010, 96(2):231-239. DOI:10.1007/s11060-009-9953-x.
[10] 黄喆慜, 葛璟洁, 张慧玮, 等. 基于11C-蛋氨酸PET显像的肿瘤代谢体积参数在脑胶质瘤诊断中的应用价值研究[J]. 肿瘤影像学, 2016, 25(3):252-256, 278. Huang ZM, Ge JJ, Zhang HW, et al. Diagnostic value of volumebased parameters by 11C-methionine PET imaging in glioma patients[J]. Oncoradiology, 2016,25(3):252-256, 278.
[11] Santoni M, Nanni C, Bittoni A, et al. 11C-methionine positron emission tomography in the postoperative imaging and followup of patients with primary and recurrent gliomas[J/OL]. ISRN Oncol, 2014:463152[2017-01-12]. https://www.hindawi.com/journals/isrn/2014/463152/. DOI:10.1155/2014/463152.
[12] Yamane T, Sakamoto S, Senda M. Clinical impact of (11)C-methionine PET on expected management of patients with brain neoplasm[J]. Eur J Nucl Med Mol Imaging, 2010, 37(4):685-690. DOI:10.1007/s00259-009-1302-y.
[13] Grosu AL, Astner ST, Riedel E, et al. An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)-and L-[methyl-11C]methionine (Met)-PET in patients with brain gliomas and metastases[J]. Int J Radiat Oncol Biol Phys, 2011, 81(4):1049-1058. DOI:10.1016/j.ijrobp.2010.07.002.
[14] Dunet V, Rossier C, Buck A, et al. Performance of 18F-fluoro-ethyltyrosine (18F-FET) PET for the differential diagnosis of primary brain tumor:a systematic review and Metaanalysis[J]. J Nucl Med,2012, 53(2):207-214. DOI:10.2967/jnumed.111.096859.
[15] Leung D, Han X, Mikkelsen T, et al. Role of MRI in primary brain tumor evaluation[J]. J Natl Compr Canc Netw, 2014, 12(11):1561-1568.
[16] Ginsberg LE, Fuller GN, Hashmi M, et al. The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults:histopathological evaluation of a series[J]. Surg Neurol,1998, 49(4):436-440.
[17] Galldiks N, Kracht LW, Dunkl V, et al. Imaging of non-or very subtle contrast-enhancing malignant gliomas with 11C-methionine positron emission tomography[J]. Mol Imaging, 2011, 10(6):453-459.
[18] Calcagni ML, Galli G, Giordano A, et al.Dynamic O-(2-[18F]fluoro-ethyl)-L-tyrosine (F-18 FET) PET for glioma grading:assessment of individual probability of malignancy[J]. Clin Nucl Med, 2011, 36(10):841-847. DOI:10.1097/RLU.0b013e3182291b40.
[19] Jansen NL, Graute V, Armbruster L, et al. MRI-suspected low-grade glioma:is there a need to perform dynamic FET PET?[J]. Eur J Nucl Med Mol Imaging, 2012, 39(6):1021-1029. DOI:10.1007/s00259-012-2109-9.
[20] Kunz M, Thon N, Eigenbrod S, et al. Hot spots in dynamic (18)FET-PET delineate malignant tumor parts within suspected WHO grade Ⅱ gliomas[J]. Neuro Oncol, 2011, 13(3):307-316. DOI:10.1093/neuonc/noq196.
[21] Albert NL, Winkelmann I, Suchorska B, et al. Early static (18)F-FET-PET scans have a higher accuracy for glioma grading than the standard 20-40 min scans[J]. Eur J Nucl Med Mol Imaging, 2016, 43(6):1105-1114. DOI:10.1007/s00259-015-3276-2.
[22] Zhao S, Kuge Y, Yi M, et al. Dynamic 11C-methionine PET analysis has an additional value for differentiating malignant tumors from granulomas:an experimental study using small animal PET[J]. Eur J Nucl Med Mol Imaging, 2011, 38(10):1876-1886. DOI:10.1007/s00259-011-1865-2.
[23] Jena A, Taneja S, Gambhir A, et al. Glioma recurrence versus radiation necrosis:Single-Session multiparametric approach using simultaneous O-(2-18F-Fluoroethyl)-L-Tyrosine PET/MRI[J/OL]. Clin Nucl Med, 2016, 41(5):e228-236[2017-01-10]. https://insights.ovid.com/pubmed?pmid=26859208. DOI:10.1097/RLU.0000000000001152.
[24] Momose T, Nariai T, Kawabe T, et al. Clinical benefit of 11C methionine PET imaging as a planning modality for radiosurgery of previously irradiated recurrent brain metastases[J]. Clin Nucl Med, 2014, 39(11):939-943. DOI:10.1097/RLU.0000000000000561.
[25] Schinkelshoek M, Lopci E, Clerici E, et al. Impact of 11C-methio-nine positron emission tomography/computed tomography on radiation therapy planning and prognosis in patients with primary brain tumors[J]. Tumori, 2015, 100(6):636-644. DOI:10.1700/1778.19268.
[26] Rieken S, Habermehl D, Giesel FL, et al. Analysis of FET-PET imaging for target volume definition in patients with gliomas treated with conformal radiotherapy[J]. Radiother Oncol, 2013, 109(3):487-492. DOI:10.1016/j.radonc.2013.06.043.
[27] Niyazi M, Geisler J, Siefert A, et al. FET-PET for malignant glioma treatment planning[J]. Radiother Oncol, 2011, 99(1):44-48. DOI:10.1016/j.radonc.2011.03.001.
[28] Piroth MD, Pinkawa M, Holy R, et al. Integrated boost IMRT with FET-PET adapted local dose escalation in glioblastomas. Results of a prospective phaseⅡ study[J]. Strahlenther Oncol, 2012, 188(4):334-349. DOI:10.1007/s00066-011-0060-5.
[29] Smits A, Westerberg E, Ribom D.Adding 11C-methionine PET to the EORTC prognostic factors in grad e 2 gliomas[J]. Eur J Nucl Med Mol Imaging, 2008, 35(1):65-71. DOI:10.1007/s00259-007-0531-1.
[30] Takano K, Kinoshita M, Arita H, et al. Diagnostic and prognostic value of 11C-methionine PET for nonenhancing gliomas[J]. AJNR Am J Neutoradiol, 2015, 37(1):44-50.
[31] Gempt J, Bette S, Ryang YM, et al. 18F-fluoro-ethyl-tyrosine positron emission tomography for grading and estimation of prognosis in patients with intracranial gliomas[J]. Eur J Radiol, 2015, 84(5):955-962. DOI:10.1016/j.ejrad.2015.01.022.
[32] Jansen NL, Suchorska B, Wenter V, et al. Prognostic significance of dynamic 18F-FET PET in newly diagnosed astrocytic high-grade glioma[J]. J Nucl Med, 2015, 56(1):9-15. DOI:10.2967/jnumed.114.144675.
[33] Juhász C, Muzik O, Chugani DC, et al. Differential kinetics of α-[11C]methyl-L-tryptophan on PET in low-grade brain tumors[J]. J Neurooncol, 2011, 102(3):409-415. DOI:10.1007/s11060-010-0327-1.
[34] Kamson DO, Mittal S, Robinette NL, et al. Increased tryptophan uptake on PET has strong independent prognostic value in patients with a previously treated high-grade glioma[J]. Neuro Oncol, 2014, 16(10):1373-1383. DOI:10.1093/neuonc/nou042.
[35] Karunanithi S, Sharma P, Kumar A, et al. 18F-FDOPA PET/CT for detection of recurrence in patients with glioma:prospective compa-rison with 18F-FDG PET/CT[J]. Eur J Nucl Med Mol Imaging, 2013, 40(7):1025-1035.DOI:10.1007/s00259-013-2384-0.
[36] Jacob MJ, Pandit AG, Jora C, et al.Comparative study of (18)F-DOPA, (13)N-Ammonia and F18-FDG PET/CT in primary brain tumors[J]. Indian J Nucl Med, 2011, 26(3):139-143. DOI:10.4103/0972-3919.103996.
[37] Wardak M, Schiepers C, Cloughesy TF, et al. 18F-FLT and 18F-FDOPA PET kinetics in recurrent brain tumors[J]. Eur J Nucl Med Mol Imaging, 2014, 41(6):1199-1209. DOI:10.1007/s00259-013-2678-2.
[38] Eidelberg D, Takikawa S, Dhawan V, et al. Striatal 18F-dopa uptake:absence of an aging effect[J]. J Cereb Blood Flow Metab, 1993, 13(5):881-888. DOI:10.1038/jcbfm.1993.110.
[39] Combs SE, Bruckner T, Mizoe JE, et al. Comparison of Carbon ion radiotherapy to photon radiation alone or in combination with temozolomide in patients with high 18F-grade gliomas:explorative hypothesis-generating retrospective analysis[J]. Radiother Oncol, 2013, 108(1):132-135. DOI:10.1016/j.radonc.2013.06.026.
[40] 高艳, 赵晋华. PET/MRI融合显像在脑胶质瘤诊断和治疗中的研究进展[J]. 国际放射医学核医学杂志, 2015, 39(1):71-79. DOI:10.3760/cma.j.issn. 1673-4114.2015.01.015. Gao Y, Zhao JH. The advancement of PET/MRI on the diagnosis and treatment of brain gliomas[J]. Int J Radiat Med Nucl Med, 2015, 39(1):71-79.
相似文献/References:
[1]李海峰,张晓军,李云钢,等.国产模块LOOP环改良法合成11C-蛋氨酸[J].国际放射医学核医学杂志,2016,40(2):106.[doi:10.3760/cma.j.issn.1673-4114.2016.02.004]
Li Haifeng,Zhang Xiaojun,Li Yungang,et al.Synthesis of 11C-methionine on home-made module by the improved LOOP method[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):106.[doi:10.3760/cma.j.issn.1673-4114.2016.02.004]
[2]程勇军,赵晋华.东亚钳蝎氯毒素在胶质瘤靶向显像与治疗中的研究进展[J].国际放射医学核医学杂志,2015,39(1):32.[doi:10.3760/cma.j.issn.1673-4114.2015.01.008]
Cheng Yongjun,Zhao Jinhua.Development of research in targeting image and therapy of gliomas using Buthus martensii Karsch chlorotoxin[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):32.[doi:10.3760/cma.j.issn.1673-4114.2015.01.008]
[3]高艳,赵晋华.PET/MRI融合显像在脑胶质瘤诊断和治疗中的研究进展[J].国际放射医学核医学杂志,2015,39(1):71.[doi:10.3760/cma.j.issn.1673-4114.2015.01.015]
Gao Yan,Zhao Jinhua.The advancement of PET/MRI on the diagnosis and treatment of brain gliomas[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):71.[doi:10.3760/cma.j.issn.1673-4114.2015.01.015]
[4]周惠君,董萍,沈国华,等.11C-蛋氨酸PET/CT显像在脑胶质瘤中的应用价值[J].国际放射医学核医学杂志,2015,39(2):161.[doi:10.3760/cma.j.issn.1673-4114.2015.02.013]
Zhou Huijun,Dong Ping,Shen Guohua,et al.Value of 11C-methionine PET/CT imaging indiagnosing cerebral glioma[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):161.[doi:10.3760/cma.j.issn.1673-4114.2015.02.013]
[5]周新韩,高明勇,张仙海,等.磁敏感加权成像显示肿瘤内静脉评价胶质瘤分级[J].国际放射医学核医学杂志,2014,38(6):373.[doi:10.3760/cma.j.issn.1673-4114.2014.06.006]
Zhou Xin-han,Gao Ming-yong,Zhang Xian-hai,et al.Values of tumor vein detected by susceptibility weighted imaging in evaluation of gliomas grade[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):373.[doi:10.3760/cma.j.issn.1673-4114.2014.06.006]
[6]李平,宗天舟,季晓芹,等.CD133+U87人脑胶质瘤干细胞放射敏感性和DNA双链断裂损伤修复的实验研究[J].国际放射医学核医学杂志,2013,37(3):153.[doi:10.3760/cma.j.issn.1673-4114.2013.03.007]
LI Ping,ZONG Tian-zhou,JI Xiao-qin,et al.CD133 positive U87 glioma stem cell radiosensitivity and DNA double-strand break repair[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(4):153.[doi:10.3760/cma.j.issn.1673-4114.2013.03.007]
[7]展凤麟,汪世存,潘博,等.11C-胆碱和18F-FDG PET/CT显像在脑胶质瘤诊断中的应用[J].国际放射医学核医学杂志,2013,37(4):193.[doi:10.3760/cma.j.issn.1673-4114.2013.04.001]
ZHAN Feng-lin,WANG Shi-cun,PAN Bo,et al.Application of 11C-choline and 18F-FDG PET/CT in diagnosing brain glioma[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(4):193.[doi:10.3760/cma.j.issn.1673-4114.2013.04.001]
[8]杨辉,张富强,李文亮,等.术中125Ⅰ粒子植入治疗复发性脑胶质瘤的临床研究[J].国际放射医学核医学杂志,2013,37(6):345.[doi:10.3760/cma.j.issn.1673-4114.2013.06.005]
YANG Hui,ZHANG Fu-qiang,LI Wen-liang,et al.Clinical study of operation combined with 125Ⅰ seeds implantation in the treatment of recurrent cerebral glioma[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(4):345.[doi:10.3760/cma.j.issn.1673-4114.2013.06.005]
[9]乐亚丽,陈跃.多种不同PET或PET/CT分子探针在胶质瘤中的应用进展[J].国际放射医学核医学杂志,2013,37(6):364.[doi:10.3760/cma.j.issn.1673-4114.2013.06.010]
LE Ya-li,CHEN Yue.Progress on application of different PET or PET/CT agents in glioma[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(4):364.[doi:10.3760/cma.j.issn.1673-4114.2013.06.010]
[10]刁焕荣,刘晓岚.MRI在颅内恶性胶质瘤放疗中的应用进展[J].国际放射医学核医学杂志,2011,35(3):185.[doi:10.3760/cma.j.issn.1673-4114.2011.03.013]
DIAO Huan-rong,LIU Xiao-lan.The use of MRI in radiotherapy of brain malignant gliomas[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(4):185.[doi:10.3760/cma.j.issn.1673-4114.2011.03.013]